TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation
Brief Summary: Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended


Options:
A: Arm Label: Dynamic needle tip positioning; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Dynamic needle tip positioning under ultrasound-guidance | Arm Label: Conventional long-axis; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional long-axis view | Intervention Type: PROCEDURE; Name: Dynamic needle tip positioning under ultrasound-guidance; Assigned to Arm(s): Dynamic needle tip positioning | Intervention Type: PROCEDURE; Name: Conventional long-axis view; Assigned to Arm(s): Conventional long-axis
B: Arm Label: CAIG; Type: EXPERIMENTAL; Interventions: Device: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Assigned to Arm(s): CAIG
C: Arm Label: Palpation only; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RAP palpation only | Arm Label: Ultrasound guidance; Type: EXPERIMENTAL; Interventions: Procedure: RAP with ultrasound guidance | Intervention Type: PROCEDURE; Name: RAP palpation only; Assigned to Arm(s): Palpation only | Intervention Type: PROCEDURE; Name: RAP with ultrasound guidance; Assigned to Arm(s): Ultrasound guidance
D: Arm Label: Arterial catheter; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Arm Label: Placement; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Intervention Type: PROCEDURE; Name: Laying a radial or femoral arterial catheter; Assigned to Arm(s): Arterial catheter, Placement

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation
Brief Summary: Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended


Options:
A: Arm Label: Ultrasound group; Type: EXPERIMENTAL; Interventions: Procedure: Ultrasound -guided cannulation | Arm Label: Palpation group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Palpation -guided cannulation | Intervention Type: PROCEDURE; Name: Ultrasound -guided cannulation; Assigned to Arm(s): Ultrasound group | Intervention Type: PROCEDURE; Name: Palpation -guided cannulation; Assigned to Arm(s): Palpation group
B: Arm Label: Seldinger; Type: EXPERIMENTAL; Interventions: Device: Ultrasound, Other: General anesthesia | Arm Label: Modified Seldinger; Type: EXPERIMENTAL; Interventions: Device: Ultrasound, Other: General anesthesia | Intervention Type: DEVICE; Name: Ultrasound; Assigned to Arm(s): Modified Seldinger, Seldinger | Intervention Type: OTHER; Name: General anesthesia; Assigned to Arm(s): Modified Seldinger, Seldinger
C: Arm Label: Oblique; Type: EXPERIMENTAL; Interventions: Procedure: radial artery Catheterization | Arm Label: Transverse group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Arm Label: Longitudinal group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: radial artery Catheterization | Intervention Type: PROCEDURE; Name: radial artery Catheterization; Assigned to Arm(s): Longitudinal group, Oblique, Transverse group
D: Arm Label: Arterial catheter; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Arm Label: Placement; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Intervention Type: PROCEDURE; Name: Laying a radial or femoral arterial catheter; Assigned to Arm(s): Arterial catheter, Placement

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Arterial Catheterization by Ultrasound: Impact on Success Rates and Complications in Patients Hospitalized in Resuscitation
Brief Summary: Monitoring of invasive blood pressure and / or cardiac output of resuscitation patients is required and recommended


Options:
A: Arm Label: Palpation group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radial arterial cannulation | Arm Label: Ultrasound group; Type: EXPERIMENTAL; Interventions: Procedure: Radial arterial cannulation | Intervention Type: PROCEDURE; Name: Radial arterial cannulation; Assigned to Arm(s): Palpation group, Ultrasound group
B: Arm Label: Dynamic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dynamic | Arm Label: Regular-triangle; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Regular-triangle | Intervention Type: BEHAVIORAL; Name: dynamic; Assigned to Arm(s): Dynamic | Intervention Type: BEHAVIORAL; Name: Regular-triangle; Assigned to Arm(s): Regular-triangle
C: Arm Label: direct palpation; Type: ACTIVE_COMPARATOR; Interventions: Device: Direct Palpation-guided Radial Artery Catheter insertion | Arm Label: Ultrasound; Type: ACTIVE_COMPARATOR; Interventions: Device: Ultrasound-guided Radial Artery Catheter Insertion | Intervention Type: DEVICE; Name: Ultrasound-guided Radial Artery Catheter Insertion; Assigned to Arm(s): Ultrasound | Intervention Type: DEVICE; Name: Direct Palpation-guided Radial Artery Catheter insertion; Assigned to Arm(s): direct palpation
D: Arm Label: Arterial catheter; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Arm Label: Placement; Type: OTHER; Interventions: Procedure: Laying a radial or femoral arterial catheter | Intervention Type: PROCEDURE; Name: Laying a radial or femoral arterial catheter; Assigned to Arm(s): Arterial catheter, Placement

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Validation of a Midwifery Model in Palestine - Usage and Quality
Brief Summary: To validate a model of Continuity of Midwifery Care implemented in the region of Nabuls and Jericho in Palestine in 2013, register data from the Palestinian Ministry of Health will be analyzed for the following indicators related to usage and quality.

Changes in these variables before and after the implementation will be compared between the 16 clinics where the model was implemented and all comparable clinics in the region.


Options:
A: Arm Label: OB Nest; Type: EXPERIMENTAL; Interventions: Other: OB Nest | Arm Label: Traditional Prenatal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: OB Nest; Assigned to Arm(s): OB Nest
B: Arm Label: ChroPreg; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ChroPreg + standard care | Arm Label: Standard care alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ChroPreg + standard care; Assigned to Arm(s): ChroPreg
C: Arm Label: Arm 1: Routine Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2:Behavioral Intervention with nudges & Facebook; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Arm 2:Behavioral Intervention with nudges & Facebook interaction | Arm Label: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.; Type: ACTIVE_COMPARATOR; Interventions: Other: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls. | Intervention Type: BEHAVIORAL; Name: Arm 2:Behavioral Intervention with nudges & Facebook interaction; Assigned to Arm(s): Arm 2:Behavioral Intervention with nudges & Facebook | Intervention Type: OTHER; Name: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.; Assigned to Arm(s): Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.
D: Arm Label: Continuity of midwifery care; Type: OTHER; Interventions: Procedure: Continuity of midwifery care | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Continuity of midwifery care; Assigned to Arm(s): Continuity of midwifery care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home-Based Extended Low Dose Buccal Misoprostol Versus Hospital-Based Standard Vaginal Dose In Management Of First Trimester Missed Abortion.
Brief Summary: The world health organization defined abortion or miscarriage as : the expulsion or extraction from its mother of a fetus or an embryo weighting 500 grams or less ,or any other wise product of gestation of any weight irrespective of gestational age and weather or not there is evidence of life and weather or not the abortion was spontaneous or induced Miscarriage is the most common complication of pregnancy occurring in 10-20% of clinically recognized pregnancies (Bag. It is estimated that around 40% of early pregnancies result in miscarriage. A large majority of those are lost before the menstrual period is missed. More than 80%of abortions occur in first 12 weeks of pregnancy, and the rate decrease there after For clinical purposes: abortion is subdivided into: threatened abortion, inevitable abortion, incomplete abortion ,missed abortion ,septic abortion ,and recurrent abortion


Options:
A: Arm Label: pitocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: mifepristone and oxytocin | Arm Label: misopristol; Type: ACTIVE_COMPARATOR; Interventions: Drug: mifepristone and misopristol | Intervention Type: DRUG; Name: mifepristone and misopristol; Assigned to Arm(s): misopristol | Intervention Type: DRUG; Name: mifepristone and oxytocin; Assigned to Arm(s): pitocin
B: Arm Label: Misoprostol 800 micrograms intravaginally; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: expectant managment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): Misoprostol 800 micrograms intravaginally
C: Arm Label: extra amniotic misoprostol; Type: EXPERIMENTAL; Interventions: Procedure: termination of second trimester pregnancy | Arm Label: vaginal misoprostol; Type: EXPERIMENTAL; Interventions: Procedure: termination of second trimester pregnancy | Intervention Type: PROCEDURE; Name: termination of second trimester pregnancy; Assigned to Arm(s): extra amniotic misoprostol, vaginal misoprostol
D: Arm Label: hospital- based vaginal misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: vaginal misoprostol | Arm Label: extended low dose oral misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: buccal/sublingual misoprostol | Intervention Type: DRUG; Name: vaginal misoprostol; Assigned to Arm(s): hospital- based vaginal misoprostol | Intervention Type: DRUG; Name: buccal/sublingual misoprostol; Assigned to Arm(s): extended low dose oral misoprostol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Brief Summary: When to start anticoagulation in patients with an acute ischaemic stroke and atrial fibrillation (AF) is a relevant unanswered question in clinical practice. Direct oral anticoagulants (DOACs) are highly effective for secondary stroke prevention in these patients, but DOACs were never initiated \<7 days after stroke onset in recent trials. The ELAN trial will determine the net benefit of early versus late initiation of DOACs in patients with acute ischaemic stroke related to AF.

The main objective is to estimate the net benefit of early versus late initiation of DOACs in patients with acute ischaemic stroke related to AF.

The secondary objectives are to assess all vascular events and all-cause mortality after early initiation of DOACs in patients with acute ischaemic stroke related to AF compared to late initiation.


Options:
A: Arm Label: Early initiation of DOAC; Type: EXPERIMENTAL; Interventions: Drug: Direct oral anticoagulant (DOAC) | Arm Label: Standard Initiation of DOAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Direct oral anticoagulant (DOAC) | Intervention Type: DRUG; Name: Direct oral anticoagulant (DOAC); Assigned to Arm(s): Early initiation of DOAC, Standard Initiation of DOAC
B: Arm Label: Dabigatran therapy; Type: EXPERIMENTAL; Interventions: Drug: Dabigatran | Arm Label: Acetylsalicylic Acid thereapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylsalicylic acid | Intervention Type: DRUG; Name: Dabigatran; Assigned to Arm(s): Dabigatran therapy | Intervention Type: DRUG; Name: Acetylsalicylic acid; Assigned to Arm(s): Acetylsalicylic Acid thereapy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: apixaban | Intervention Type: DRUG; Name: warfarin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: apixaban; Assigned to Arm(s): 2
D: Arm Label: Early treatment; Type: EXPERIMENTAL; Interventions: Drug: Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®) | Arm Label: Late treatment; Type: OTHER; Interventions: Drug: Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®) | Intervention Type: DRUG; Name: Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®); Assigned to Arm(s): Early treatment | Intervention Type: DRUG; Name: Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®); Assigned to Arm(s): Late treatment

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Misoprostol Versus Expectant Management in Women With Incomplete First-trimester Miscarriage After Misoprostol Treatment: A Randomized Clinical Trial
Brief Summary: Miscarriage is defined as the spontaneous loss of a pregnancy before 24 weeks' gestation, that is, before the fetal viability. The clinical signs of miscarriage are usually vaginal bleeding associated abdominal pain and cramping . The miscarriage is named 'complete' or 'incomplete' according to whether or not tissues are retained in the uterus. If a woman has minimal bleeding but her cervix is closed, this is known as a 'threatened miscarriage. However; if the pregnancy is still inside the uterus but the cervix is open, this is described as an 'inevitable miscarriage', which it will not usually be possible to save the fetus.

From many years, the surgical curettage ('evacuation of the uterus') was considered the 'gold standard management' for miscarriage to remove the retained placental tissue. It is quickly performed and removed almost all the retained products of conception. However, the routine surgical evacuation of the uterus associated with higher rate of morbidity and mortality and should be limited for special indications.

Many studies compared the effectiveness of medical treatment compared to surgery in management of incomplete abortion. There is only one study compared the curettage with expectant management in those women after medical therapy.However; none of them, looked at the effectiveness of the second chance of medical treatment in management of incomplete abortion in trial to avoid the surgical intervention after failure of previous medical treatment. So we think that the immediate evacuation using surgical intervention is truly unnecessary in most cases of failed medical abortion and the patients may get benefit from another trial of medical treatment.


Options:
A: Arm Label: PO Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Arm Label: PV Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Arm Label: Buccal Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol (cytotec) | Intervention Type: DRUG; Name: Misoprostol (cytotec); Assigned to Arm(s): Buccal Misoprostol, PO Misoprostol, PV Misoprostol
B: Arm Label: Misoprostol group; Type: OTHER; Interventions: Drug: Misoprostol | Arm Label: Expectant group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol group
C: Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): N/A
D: Arm Label: Misoprostol by physician; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Misoprostol treatment by midwife | Arm Label: Misoprostol by midwife; Type: EXPERIMENTAL; Interventions: Procedure: Misoprostol treatment by midwife | Intervention Type: PROCEDURE; Name: Misoprostol treatment by midwife; Assigned to Arm(s): Misoprostol by midwife, Misoprostol by physician

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Mirror Therapy in Patients With Amputations of Lower Limbs of Vascular Origin
Brief Summary: The aim of this study is to assess the efficacy of the mirror therapy on phantom pain for patients with amputation after vascular etiology. the secondary aim are to measure the impact of the mirror therapy on quality of life, sleep disorders, and predictive factors for effectiveness. the design is a prospective study, randomised, blindly evaluated, monocentric. There will be 2 groups: 1) rehabilitation and gabapentine; 2) rehabilitation and gabapentine + mirror therapy during the first 4 weeks. The assessment are going to be preformed at the inclusion day and then every 2 weeks during 8 weeks. the primary evaluation criterion will be the phantom pain measured on a VAS. the delay for inclusion is 18 months in order ton include 40 patients. The length of the study is 20 months.


Options:
A: Arm Label: Treatment Traditional and Motor Imaginary Program; Type: EXPERIMENTAL; Interventions: Other: Treatment Traditional and Imaginary Motor Program | Arm Label: Treatment Traditional and Mirror Therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Traditional and Mirror Therapy | Intervention Type: OTHER; Name: Treatment Traditional and Imaginary Motor Program; Assigned to Arm(s): Treatment Traditional and Motor Imaginary Program | Intervention Type: OTHER; Name: Treatment Traditional and Mirror Therapy; Assigned to Arm(s): Treatment Traditional and Mirror Therapy
B: Arm Label: Virtual reality gait rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Virtual Reality Gait Training | Arm Label: Treadmill training gait rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Treadmill Gait Training | Intervention Type: OTHER; Name: Virtual Reality Gait Training; Assigned to Arm(s): Virtual reality gait rehabilitation | Intervention Type: OTHER; Name: Treadmill Gait Training; Assigned to Arm(s): Treadmill training gait rehabilitation
C: Arm Label: Not Meeting Mobility Goals; Type: EXPERIMENTAL; Interventions: Other: Needs-based intervention (physical, psychological, or both) | Intervention Type: OTHER; Name: Needs-based intervention (physical, psychological, or both); Assigned to Arm(s): Not Meeting Mobility Goals
D: Arm Label: Reference analgesic; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gabapentin, Procedure: Rehabilitation, Other: Local care | Arm Label: reference analgesic and mirror therapy; Type: EXPERIMENTAL; Interventions: Procedure: Mirror Therapy, Drug: Gabapentin, Procedure: Rehabilitation, Other: Local care | Intervention Type: PROCEDURE; Name: Mirror Therapy; Assigned to Arm(s): reference analgesic and mirror therapy | Intervention Type: DRUG; Name: Gabapentin; Assigned to Arm(s): Reference analgesic, reference analgesic and mirror therapy | Intervention Type: PROCEDURE; Name: Rehabilitation; Assigned to Arm(s): Reference analgesic, reference analgesic and mirror therapy | Intervention Type: OTHER; Name: Local care; Assigned to Arm(s): Reference analgesic, reference analgesic and mirror therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adolescent Coordinated Transition (ACT) to Improve Health Outcomes Among Nigerian HIV+ Youth
Brief Summary: The purpose of this study is to evaluate the comparative effectiveness of a comprehensive, coordinated transition protocol which includes an early introduction to the adult provider, an integrated case management team and a peer-facilitated organized support group on retention in care, viral suppression and psychosocial wellbeing among adolescents living with HIV.


Options:
A: Arm Label: Mentor Mothers Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer support and mentoring | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer support and mentoring; Assigned to Arm(s): Mentor Mothers Intervention
B: Arm Label: Parenting Training; Type: EXPERIMENTAL; Interventions: Behavioral: Skilful Parenting | Arm Label: Agricultural Training; Type: EXPERIMENTAL; Interventions: Other: Agrics | Arm Label: Parenting and Agricultural Training; Type: EXPERIMENTAL; Interventions: Behavioral: Skilful Parenting, Other: Agrics | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Skilful Parenting; Assigned to Arm(s): Parenting Training, Parenting and Agricultural Training | Intervention Type: OTHER; Name: Agrics; Assigned to Arm(s): Agricultural Training, Parenting and Agricultural Training
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ACT Intervention; Type: EXPERIMENTAL; Interventions: Other: ACT | Intervention Type: OTHER; Name: ACT; Assigned to Arm(s): ACT Intervention
D: Arm Label: mSBIRT; Type: EXPERIMENTAL; Interventions: Behavioral: Screening, Brief Intervention, Referral to Treatment | Arm Label: SBIRT-CTS),; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Screening, Brief Intervention, Referral to Treatment | Intervention Type: BEHAVIORAL; Name: Screening, Brief Intervention, Referral to Treatment; Assigned to Arm(s): SBIRT-CTS),, mSBIRT

Answer: C